Mia Malone

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail

Joshua D. Lee, Mia Malone, Ryan McDonald et al. · JAMA Network Open · 2021 · 64 citations · Full text

Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study

Anna Cheng, Ryan Badolato, Andrew Segoshi et al. · Addiction Science & Clinical Practice · 2022 · 30 citations · Full text

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)

Elizabeth Needham Waddell, Sandra A. Springer, Lisa A. Marsch et al. · Journal of Substance Abuse Treatment · 2021 · 23 citations · Full text

Opioid Epidemic, Substance Abuse, Substance Use +12

Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration

Jan Gryczynski, Joshua D. Lee, Kristi Dušek et al. · Journal of Substance Abuse Treatment · 2021 · 21 citations · Full text

Opioid Epidemic, Substance Use, Criminal Justice Reform +26

Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON)

Mia Malone, Ryan McDonald, Alex Vittitow et al. · Contemporary Clinical Trials · 2019 · 16 citations · Full text

Oral Naltrexone, Substance Abuse, Primary Care +13